Celldex Therapeutics
CLDX
CLDX
193 hedge funds and large institutions have $2.43B invested in Celldex Therapeutics in 2015 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 61 increasing their positions, 54 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16% less call options, than puts
Call options by funds: $51.6M | Put options by funds: $61.4M
Holders
193
Holding in Top 10
1
Calls
$51.6M
Puts
$61.4M
Top Buyers
| 1 | +$132M | |
| 2 | +$55.5M | |
| 3 | +$30.3M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$25M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$19.9M |
Top Sellers
| 1 | -$40.8M | |
| 2 | -$27.5M | |
| 3 | -$25M | |
| 4 |
CCI
Columbus Circle Investors
|
-$18.9M |
| 5 |
TCMG
TSP Capital Management Group
Summit,
New Jersey
|
-$15.4M |